TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Epigallocatechin gallate, Irinotecan
Phytochemical Name Epigallocatechin gallate (PubChem CID: 65064 )
Anticancer drug Name Irinotecan (PubChem CID: 60838 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Decreasing Drug Toxicity
Hide/Show
Combination Pair ID: 126
Pair Name Epigallocatechin gallate, Irinotecan
Disease Info [ICD-11: 2B91] Colorectal cancer Investigative
Biological Phenomena Induction-->DNA damage
Gene Regulation Down-regulation Expression CCNB1 hsa891
Down-regulation Expression CCND1 hsa595
Down-regulation Expression CDK4 hsa1019
Up-regulation Expression MAP1LC3A hsa84557
Up-regulation Phosphorylation RB1 hsa5925
Down-regulation Expression TOP1 hsa7150
In Vitro Model RKO Colon carcinoma Homo sapiens (Human) CVCL_0504
HCT 116 Colon carcinoma Homo sapiens (Human) CVCL_0291
Result EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 455
Pair Name Epigallocatechin gallate, Irinotecan
Disease Info [ICD-11: 2B91] Colorectal cancer Investigative
Biological Phenomena Induced-->GRP78-mediated endoplasmic reticulum stress
Gene Regulation Down-regulation Expression BCL2 hsa596
Up-regulation Expression GRP78 KEGG ID N.A.
Down-regulation Expression ROS1 hsa6098
In Vitro Model HCT 116 Colon carcinoma Homo sapiens (Human) CVCL_0291
RKO Colon carcinoma Homo sapiens (Human) CVCL_0504
In Vivo Model The concentration of HCT116 cells in the logarithmic phase was adjusted to 2.5×10⁷/mL, and the 200 μL cell suspension was inoculated subcutaneously on the right dorsal side of the mouse. When the average tumor volume reached 100 mm3, animals were randomized into 4 groups (5 mice for each group), control (Control, normal saline, 1 time per day, ip), irinotecan (IRI, 4 mg/kg irinotecan, 2 times per week, ip), EGCG (EGCG, 5 mg/kg, 1 time per day, ip), and irinotecan in combination with EGCG (IRI + EGCG).
Result These reults confirmed that EGCG alone or in combination with irinotecan could up-regulate the GRP78, activate ERS of colorectal cancer cells, reduce intracellular reactive oxygen species and mitochondrial membrane potential, and induce apoptosis. The mouse xenograft experiment also confirmed the synergistic effect of EGCG and irinotecan on ERS and tumor cell.EGCG can induce GRP78-mediated endoplasmic reticulum stress and enhance the chemo-sensitivity of colorectal cancer cells when coadministered with irinotecan.
Antagonistic Effect
Hide/Show
Reducing Drug Efficacy
Hide/Show
Combination Pair ID: 1091
Pair Name Epigallocatechin gallate, Irinotecan
Disease Info [ICD-11: 2A00-2F9Z] Solid tumour or cancer Investigative
Biological Phenomena Inhibition-->P-gp expression
In Vivo Model Adult, male Sprague–Dawley rats (300 ± 20 g body weight) were provided by the Laboratory Animal Center at National Yang-Ming University, the rats were initially anaesthetized with urethane 1 g/mL and α-chloralose 0.1 g/mL (1 mL/kg, i.p.), and remained anaesthetized throughout the experimental period. The femoral vein was exposed for further drug administration.
Result EGCG was found to inhibit the transport of CPT-11 and SN-38 into the biliary elimination and their half-lives in plasma could be substantially prolonged. Based on the food-drug interaction, persons taking daily nutritional supplements should be warned of this interaction possibility.
03. Reference
No. Title Href
1 Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38. Chem Biol Interact. 2008;174(3):177-182. doi:10.1016/j.cbi.2008.05.033 Click
2 EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells. J Cell Mol Med. 2021 Aug;25(16):7913-7921. doi: 10.1111/jcmm.16718. Click
3 EGCG Enhances the Chemosensitivity of Colorectal Cancer to Irinotecan through GRP78-MediatedEndoplasmic Reticulum Stress. J Oncol. 2022;2022:7099589. Published 2022 Sep 13. doi:10.1155/2022/7099589 Click
It has been 26743 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP